$INTT

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

Original reporting
Published Aug 3, 2026, 11:17 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$INTT
Bullish
medium confidence
Mentioned
$INTT
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$INTTBullishMed
01

Why it matters

For traders, the actionable elements are the same-day analyst upgrade with a stated $15 price target and the company’s raised FY revenue range, which can drive estimate revisions. The planned gross margin reduction is a material offset that may affect valuation multiples and near-term expectations.

02

Market read

Company-specific catalysts (upgrade plus raised revenue outlook) are the primary driver, with a supportive broader market backdrop amplifying the move.

03

What to watch

Preliminary results and guidance can change quickly; traders may fade the move if subsequent filings or margin commentary disappoint.

Relevance 7/10Novelty 7/10Timing: pre-open today

Background

The article attributes inTest’s pre-open climb to a Northland upgrade and a preliminary Q2 update released July 31, plus a raised full-year revenue outlook.

Company-level read

Ticker impact

$INTTBullishMedium confidence
Context

inTest shares rose pre-open after Northland upgraded the stock to outperform and set a $15 target, alongside raised FY revenue guidance.

Expected impact

Likely continued relative strength early as traders price the raised revenue outlook, but upside may be capped by the gross margin downgrade.

Evidence & confidence

The article cites a same-day analyst rating change with a specific price target and a preliminary Q2 revenue estimate plus raised FY outlook, which are direct catalysts for sentiment and estimates. The gross margin revision is a counterweight but is framed as not requiring amendments to filed reports.

Market effects

Positive read-through for semiconductor equipment and industrial testing sentiment, as the article links the move to sector optimism.

Primarily U.S. market sentiment tailwind via S&P 500, Dow, and Nasdaq gains.

Limited direct global linkage beyond general risk appetite and sector sentiment.

Counterpoint

The gross margin downgrade (220 bps) could signal cost pressure or demand mix issues, making the revenue raise less bullish than it appears.

Key entities

  • inTest Corporation

    Subject of the article, with shares up pre-open on an analyst upgrade and raised revenue outlook.

  • Northland

    Upgraded inTest from market perform to outperform and set a $15 price target.

Related articles

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 intt-20260731xpaexx991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million •

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.